Literature DB >> 9855537

Molecular mimicry in chronic inflammatory demyelinating polyneuropathy and melanoma.

M D Weiss1, C A Luciano, C Semino-Mora, M C Dalakas, R H Quarles.   

Abstract

Polyclonal immunoglobulin M antibodies to the monosialoganglioside GM2, sulfoglucuronyl glycolipids, and sulfatide were detected by thin-layer chromatography and enzyme-linked immunosorbent assay in the serum of a patient with melanoma and chronic inflammatory demyelinating polyneuropathy. Both the patient's serum and polyclonal antibodies against GM2 reacted strongly with a biopsy of melanomatous tissue from the patient, suggesting a process of molecular mimicry.

Entities:  

Mesh：

Substances：

Year:  1998        PMID： 9855537     DOI： 10.1212/wnl.51.6.1738

Source DB:  PubMed          Journal:  Neurology        ISSN： 0028-3878            Impact factor:   9.910


  12 in total

1.  Partial resolution of acute ascending motor polyneuropathy after enucleation of an eye with metastatic melanoma.

Authors:  G J Ben Simon; J D McCann; N Barth; R A Goldberg; B J Glasgow; B R Straatsma
Journal:  Br J Ophthalmol       Date:  2004-06       Impact factor: 4.638

2.  Chronic inflammatory polyneuropathy revealing malignant melanoma.

Authors:  A Rousseau; F Salachas; M Baccard; J Y Delattre; M Sanson
Journal:  J Neurooncol       Date:  2005-02       Impact factor: 4.130

3.  Chronic idiopathic demyelinating polyneuropathy (CIDP) associated with Kaposi's sarcoma.

Authors:  Yahya Celik; Nilda Turgut; Burhan Turgut; Gülsüm E Pamuk; Muzaffer Demir
Journal:  J Neurooncol       Date:  2006-06-23       Impact factor: 4.130

Review 4.  Advances in the diagnosis, pathogenesis and treatment of CIDP.

Authors:  Marinos C Dalakas
Journal:  Nat Rev Neurol       Date:  2011-08-16       Impact factor: 42.937

Review 5.  Neurologic Immune-Related Adverse Events Associated with Immune Checkpoint Inhibition.

Authors:  Peter Chei-Way Pan; Aya Haggiagi
Journal:  Curr Oncol Rep       Date:  2019-11-27       Impact factor: 5.075

6.  Neurologic Toxicities of Immunotherapy.

Authors:  Rebecca A Harrison; Nazanin K Majd; Sudhakar Tummala; John F de Groot
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

7.  Cancer regression and neurological toxicity following anti-MAGE-A3 TCR gene therapy.

Authors:  Richard A Morgan; Nachimuthu Chinnasamy; Daniel Abate-Daga; Alena Gros; Paul F Robbins; Zhili Zheng; Mark E Dudley; Steven A Feldman; James C Yang; Richard M Sherry; Giao Q Phan; Marybeth S Hughes; Udai S Kammula; Akemi D Miller; Crystal J Hessman; Ashley A Stewart; Nicholas P Restifo; Martha M Quezado; Meghna Alimchandani; Avi Z Rosenberg; Avindra Nath; Tongguang Wang; Bibiana Bielekova; Simone C Wuest; Nirmala Akula; Francis J McMahon; Susanne Wilde; Barbara Mosetter; Dolores J Schendel; Carolyn M Laurencot; Steven A Rosenberg
Journal:  J Immunother       Date:  2013-02       Impact factor: 4.456

8.  Chronic inflammatory demyelinating polyneuropathy associated with metastatic malignant melanoma of unknown primary origin.

Authors:  José-Alberto Palma; Salvador Martín-Algarra
Journal:  J Neurooncol       Date:  2009-03-06       Impact factor: 4.130

Review 9.  Association between chronic inflammatory demyelinating polyneuropathy and gastrointestinal malignancies.

Authors:  Adnan Malik; Rani Berry; Brian M Fung; James H Tabibian
Journal:  Clin J Gastroenterol       Date:  2020-11-04

Review 10.  Molecular mimicry as a mechanism of autoimmune disease.

Authors:  Matthew F Cusick; Jane E Libbey; Robert S Fujinami
Journal:  Clin Rev Allergy Immunol       Date:  2012-02       Impact factor: 8.667
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.